A trial comparing two corticoid preparations for the treatment of eczematous skin disorders.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001530:Belgium; D002648:Child; D002675:Child, Preschool; D003872:Dermatitis / Q000188:drug therapy*; D003907:Dexamethasone / Q000627:therapeutic use*; D004338:Drug Combinations; D005163:Factor Analysis, Statistical; D005260:Female; D005446:Fluocinolone Acetonide / Q000627:therapeutic use*; D005860:Germany, West; D006561:Herpes Simplex / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009277:Nandrolone / Q000627:therapeutic use; D009426:Netherlands; D009824:Ointments; D010915:Pityriasis / Q000188:drug therapy; D011538:Pruritus Ani / Q000188:drug therapy; D012869:Skin Absorption
D004338:Drug Combinations; D007093:Imidazoles; D009824:Ointments; D005446:Fluocinolone Acetonide; D009277:Nandrolone; D003907:Dexamethasone